Literature DB >> 17710842

Carotid thrombus formation and extension during anticoagulation: a case report of large vessel disease and hypercoagulable state in systemic sclerosis.

Dimitri Renard1, Chérif Heroum.   

Abstract

Systemic sclerosis (SSc) is an autoimmune multisystem disorder of connective tissue characterized by widespread vascular lesions and fibrosis. Limited cutaneous systemic sclerosis (lcSSc) and diffuse cutaneous systemic sclerosis (dsSSC) are both subsets of SSc. The vascular component of SSc is an important part of the disease. Especially Raynaud's phenomenon and microcirculatory abnormalities are well recognized. Enhanced coagulation pathways, decreased fibrinolysis, and endothelial dysfunction probably contribute to vascular events in SSc. Macrovascular disease is not recognized as a major feature of SSc. However, several studies report an increase in large vessel disease and mortality rate attributable to cardiovascular causes. We present a patient with lcSSc with an acute embolic stroke due to a large carotid thrombus. A hypercoagulable state was suspected because of thrombus formation during oral anticoagulation and extension during intravenous heparin treatment. This is one of the few reports of large vessel disease in systemic sclerosis. The hypercoagulable state may be related to systemic sclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17710842

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  2 in total

1.  Floating Thrombus in the Ascending Aorta of the Patient with Systemic Sclerosis - A case report -.

Authors:  Sub Lee; Jun-Woo Cho; Oh-Choon Kwon
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2011-02-12

2.  Carotid free-floating thrombus during COVID-19 vaccine era: causality or not?

Authors:  Ludovica Ferraù; Fabrizio Giammello; Masina Cotroneo; Cristina Dell'Aera; Francesco Grillo; Teresa Brizzi; Antonio Pitrone; Sergio Lucio Vinci; Rosa Fortunata Musolino; Paolino La Spina
Journal:  Neurol Sci       Date:  2022-08-03       Impact factor: 3.830

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.